Search Results 31-40 of 11379 for anti-TNF drugs

  1. A Study Of The Effectiveness And Safety Of Vedolizumab Compared To Adalimumab For Participants With Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...

  2. Adalimumab is the first biologic approved by the U.S. Food and Drug Administration for the treatment of hidradenitis suppurativa. These drugs work by ...

  3. Baricitinib (oral route) - Side effects & dosage - Mayo Clinic

    ... TNF antagonist) that did not work well. ... Adalimumab; Adenovirus Vaccine Type 4, Live; Adenovirus ... drugs may be the best treatment for you. If both ...

  4. Ankylosing spondylitis - Diagnosis & treatment - Mayo Clinic

    These types of medicines can reactivate untreated tuberculosis and make you more prone to infections. Examples of TNF blockers include: Adalimumab (Humira).

  5. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    Examples include infliximab (Remicade), adalimumab (Humira), certolizumab pegol (Cimzia), vedolizumab (Entyvio), ustekinumab (Stelara), risankizumab (Skyrizi), ...

  6. Rheumatoid arthritis - Diagnosis and treatment - Mayo Clinic

    Biologic agents. Also known as biologic response modifiers, this newer class of DMARDs includes abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), ...

  7. Medications. Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or naproxen, may help reduce pain and stiffness. While these medications can ...

  8. Drugs and Supplements that Start with A - Mayo Clinic

    Drugs and Supplements. Search prescription and over-the-counter drugs . ... Adalimumab-aacf (subcutaneous route) · Adalimumab-aaty (subcutaneous route).

  9. Tocilizumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine helps keep joint damage from getting worse after other medicines (eg, adalimumab, etanercept, infliximab) have been used and did not work well.

  10. Safety And Efficacy Of Adalimumab Versus Ustekinumab For One Year - Mayo Clinic

    The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely ...